Differential binding of Shiga toxin 2 to human and murine neutrophils

Journal of Medical Microbiology

Volumn 56, Issue 11, 2007, Pages 1423-1430

  Griener, Thomas P ^a   Mulvey, George L ^a   Marcato, Paola ^b   Armstrong, Glen D ^a  

^a Health Sciences Centre Calgary   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID P COMPONENT; GLOBOTRIAOSYLCERAMIDE; VEROTOXIN 2;

ANIMAL EXPERIMENT; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PURIFICATION;

ANIMALS; CELLS, CULTURED; HUMANS; MICE; NEUTROPHILS; SERUM AMYLOID P-COMPONENT; SHIGA TOXIN 2; TRIHEXOSYLCERAMIDES;

EID: 36448958290     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.47282-0     Document Type: Article

References (30)

1. Armstrong, G. D., Mulvey, G. L., Marcato, P., Griener, T. P., Kahan, M. C., Tennent, G. A., Sabin, C. A., Chart, H. & Pepys, M. B. (2006). Human serum amyloid P component protects against Escherichia coli O157:H7 Shiga toxin 2 in vivo: therapeutic implications for hemolytic-uremic syndrome. J Infect Dis 193, 1120-1124.
2. Beutin, L., Krause, G., Zimmermann, S., Kaulfuss, S. & Gleier, K. (2004). Characterization of Shiga toxin-producing Escherichia coli strains isolated from human patients in Germany over a 3-year period. J Clin Microbiol 42, 1099-1108.
3. Bitzan, M., Richardson, S., Huang, C., Boyd, B., Petric, M. & Karmali, M. A. (1994). Evidence that Verotoxins (Shiga-like toxins) from Escherichia coli bind to P blood group antigens of human erythrocytes in vitro. Infect Immun 62, 3337-3347.
4. Brigotti, M., Caprioli, A., Tozzi, A. E., Tazzari, P. L., Ricci, F., Conte, R., Carnicelli, D., Procaccino, M. A., Minelli, F. & other authors (2006). Shiga toxins present in the gut and in the polymorphonuclear leukocytes circulating in the blood of children with hemolytic-uremic syndrome. J Clin Microbiol 44, 313-317.
5. Cherla, R. P., Lee, S. Y. & Tesh, V. L. (2003). Shiga toxins and apoptosis. FEMS Microbiol Lett 228, 159-166.
6. Downey, G. P., Doherty, D. E., Schwab, B., III, Elson, E. L., Henson, P. M. & Worthen, G. S. (1990). Retention of leukocytes in capillaries: role of cell size and deformability. J Appl Physiol 69, 1767-1778.
7. Flagler, M. J., Strasser, J. E., Chalk, C. L. & Weiss, A. A. (2007). Comparative analysis of the abilities of Shiga toxins 1 and 2 to bind to and influence neutrophil apoptosis. Infect Immun 75, 760-765.
8. Fraser, M. E., Fujinaga, M., Cherney, M. M., Melton-Celsa, A. R., Twiddy, E. M., O'Brien, A. D. & James, M. N. (2004). Structure of Shiga toxin type 2 (Stx2) from Escherichia coli O157:H7. J Biol Chem 279, 27511-27517.
9. Fukuda, M. N., Dell, A., Oates, J. E., Wu, P., Klock, J. C. & Fukuda, M. (1985). Structures of glycosphingolipids isolated from human granulocytes. The presence of a series of linear poly-N-acetyllactosaminylceramide and its significance in glycolipids of whole blood cells. J Biol Chem 260, 1067-1082.
10. Geelen, J. M., van der Velden, T. J., Te Loo, D. M., Boerman, O. C., van den Heuvel, L. P. & Monnens, L. A. (2007). Lack of specific binding of Shiga-like toxin (Verocytotoxin) and non-specific interaction of Shiga-like toxin 2 antibody with human polymorphonuclear leucocytes. Nephrol Dial Transplant 22, 749-755.
11. Hawkins, P. N., Tennent, G. A., Woo, P. & Pepys, M. B. (1991). Studies in vivo and in vitro of serum amyloid P component in normals and in a patient with AA amyloidosis. Clin Exp Immunol 84, 308-316.
12. Head, S. C., Karmali, M. A. & Lingwood, C. A. (1991). Preparation of VT1 and VT2 hybrid toxins from their purified dissociated subunits. Evidence for B subunit modulation of a subunit function. J Biol Chem 266, 3617-3621.
13. Kaplan, B. S., Meyers, K. E. & Schulman, S. L. (1998). The pathogenesis and treatment of hemolytic uremic syndrome. J Am Soc Nephrol 9, 1126-1133.
14. Karmali, M. A., Petric, M., Lim, C., Fleming, P. C. & Steele, B. T. (1983). Escherichia coli cytotoxin, haemolytic-uraemic syndrome, and haemorrhagic colitis. Lancet 2, 1299-1300.
15. Kimura, T., Tani, S., Matsumoto Yi, Y. & Takeda, T. (2001). Serum amyloid P component is the Shiga toxin 2-neutralizing factor in human blood. J Biol Chem 276, 41576-41579.
16. Kitov, P. I., Sadowska, J. M., Mulvey, G., Armstrong, G. D., Ling, H., Pannu, N. S., Read, R. J. & Bundle, D. R. (2000). Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligands. Nature 403, 669-672.
17. Kuligowski, M. P., Kitching, A. R. & Hickey, M. J. (2006). Leukocyte recruitment to the inflamed glomerulus: a critical role for platelet-derived P-selectin in the absence of rolling. J Immunol 176, 6991-6999.
18. Liu, J., Akahoshi, T., Sasahana, T., Kitasato, H., Namai, R., Sasaki, T., Inoue, M. & Kondo, H. (1999). Inhibition of neutrophil apoptosis by Verotoxin 2 derived from Escherichia coli O157:H7. Infect Immun 67, 6203-6205.
19. Macher, B. A. & Klock, J. C. (1980). Isolation and chemical characterization of neutral glycosphingolipids of human neutrophils. J Biol Chem 255, 2092-2096.
20. Marcato, P., Vander Helm, K., Mulvey, G. L. & Armstrong, G. D. (2003). Serum amyloid P component binding to Shiga toxin 2 requires both A subunit and B pentamer. Infect Immun 71, 6075-6078.
21. Menge, C., Eisenberg, T., Stamm, I. & Baljer, G. (2006). Comparison of binding and effects of Escherichia coli Shiga toxin 1 on bovine and ovine granulocytes. Vet Immunol Immunopathol 113, 392-403.
22. Mulvey, G., Vanmaele, R., Mrazek, M., Cahill, M. & Armstrong, G. (1998). Affinity purification of Shiga-like toxin I and Shiga-like toxin II. J Microbiol Methods 32, 247-252.
23. Mulvey, G. L., Marcato, P., Kitov, P. I., Sadowska, J., Bundle, D. R. & Armstrong, G. D. (2003). Assessment in mice of the therapeutic potential of tailored, multivalent Shiga toxin carbohydrate ligands. J Infect Dis 187, 640-649.
24. Nataro, J. P. & Kaper, J. B. (1998). Diarrheagenic Escherichia coli. Clin Microbiol Rev 11, 142-201.
25. Taguchi, T., Uchida, H., Kiyokawa, N., Mori, T., Sato, N., Horie, H., Takeda, T. & Fujimoto, J. (1998). Verotoxins induce apoptosis in human renal tubular epithelium derived cells. Kidney Int 53, 1681-1688.
26. Tazzari, P. L., Ricci, F., Carnicelli, D., Caprioli, A., Tozzi, A. E., Rizzoni, G., Conte, R. & Brigotti, M. (2004). Flow cytometry detection of Shiga toxins in the blood from children with hemolytic uremic syndrome. Cytometry B Clin Cytom 61, 40-44.
27. te Loo, D. M., Monnens, L. A., van Der Velden, T. J., Vermeer, M. A., Preyers, F., Demacker, P. N., van Den Heuvel, L. P. & van Hinsbergh, V. W. (2000). Binding and transfer of Verocytotoxin by polymorphonuclear leukocytes in hemolytic uremic syndrome. Blood 95, 3396-3402.
28. te Loo, D. M., Heuvelink, A. E., de Boer, E., Nauta, J., van der Walle, J., Schroder, C., van Hinsbergh, V. W., Chart, H., van de Kar, N. C. & van den Heuvel, L. P. (2001a). Vero cytotoxin binding to polymorphonuclear leukocytes among households with children with hemolytic uremic syndrome. J Infect Dis 184, 446-450.
29. te Loo, D. M., van Hinsbergh, V. W., van den Heuvel, L. P. & Monnens, L. A. (2001b). Detection of Verocytotoxin bound to circulating polymorphonuclear leukocytes of patients with hemolytic uremic syndrome. J Am Soc Nephrol 12, 800-806.
30. Winter, K. R., Stoffregen, W. C. & Dean-Nystrom, E. A. (2004). Shiga toxin binding to isolated porcine tissues and peripheral blood leukocytes. Infect Immun 72, 6680-6684.